Cargando…
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms
Despite major advancements in lung cancer treatment, long-term survival is still rare, and a deeper understanding of molecular phenotypes would allow the identification of specific cancer dependencies and immune evasion mechanisms. Here we performed in-depth mass spectrometry (MS)-based proteogenomi...
Autores principales: | Lehtiö, Janne, Arslan, Taner, Siavelis, Ioannis, Pan, Yanbo, Socciarelli, Fabio, Berkovska, Olena, Umer, Husen M., Mermelekas, Georgios, Pirmoradian, Mohammad, Jönsson, Mats, Brunnström, Hans, Brustugun, Odd Terje, Purohit, Krishna Pinganksha, Cunningham, Richard, Asl, Hassan Foroughi, Isaksson, Sofi, Arbajian, Elsa, Aine, Mattias, Karlsson, Anna, Kotevska, Marija, Hansen, Carsten Gram, Haakensen, Vilde Drageset, Helland, Åslaug, Tamborero, David, Johansson, Henrik J., Branca, Rui M., Planck, Maria, Staaf, Johan, Orre, Lukas M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612062/ https://www.ncbi.nlm.nih.gov/pubmed/34870237 http://dx.doi.org/10.1038/s43018-021-00259-9 |
Ejemplares similares
-
Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC
por: Langberg, Christian Wilhelm, et al.
Publicado: (2023) -
Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease
por: Eide, Hanne Astrid, et al.
Publicado: (2016) -
Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC—A retrospective single-center experience
por: Karadzovska-Kotevska, Marija, et al.
Publicado: (2022) -
Methylation Patterns and Chromatin Accessibility in Neuroendocrine Lung Cancer
por: Arbajian, Elsa, et al.
Publicado: (2020) -
Molecular characterisation of TP53 mutated squamous cell carcinomas of the lung to identify putative targets for therapy
por: Haakensen, Vilde D., et al.
Publicado: (2020)